Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Nonsteroidal androgen receptor ligands: versatile syntheses and biological data.

Varchi G, Guerrini A, Tesei A, Brigliadori G, Bertucci C, Di Donato M, Castoria G.

ACS Med Chem Lett. 2012 Apr 10;3(6):454-8. doi: 10.1021/ml3000269. eCollection 2012 Jun 14.

2.

Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity.

Tesei A, Brigliadori G, Carloni S, Fabbri F, Ulivi P, Arienti C, Sparatore A, Del Soldato P, Pasini A, Amadori D, Silvestrini R, Zoli W.

J Cell Physiol. 2012 Oct;227(10):3389-96. doi: 10.1002/jcp.24039.

PMID:
22212895
3.

Activity of different anthracycline formulations in hormone-refractory prostate cancer cell lines: role of Golgi apparatus.

Fabbri F, Zoli W, Carloni S, Ulivi P, Arienti C, Brigliadori G, Montanari M, Tesei A, Silvestrini R, Amadori D.

J Cell Physiol. 2011 Nov;226(11):3035-42. doi: 10.1002/jcp.22654.

PMID:
21302303
4.

Tyrosine kinase inhibitors gefitinib, lapatinib and sorafenib induce rapid functional alterations in breast cancer cells.

Carloni S, Fabbri F, Brigliadori G, Ulivi P, Silvestrini R, Amadori D, Zoli W.

Curr Cancer Drug Targets. 2010 Jun;10(4):422-31.

PMID:
20384581
5.

Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models.

Tesei A, Leonetti C, Zupi G, Scarsella M, Brigliadori G, Ulivi P, Fabbri F, Arienti C, Amadori D, Passardi A, Silvestrini R, Zoli W.

J Cell Mol Med. 2011 Feb;15(2):316-26. doi: 10.1111/j.1582-4934.2009.00993.x.

PMID:
20015197
6.

Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expression.

Fabbri F, Brigliadori G, Carloni S, Ulivi P, Tesei A, Silvestrini R, Amadori D, Zoli W.

Prostate. 2010 Feb 1;70(2):219-27. doi: 10.1002/pros.21055.

PMID:
19790230
7.

Role of efflux pump activity in lapatinib/caelyx combination in breast cancer cell lines.

Vannini I, Zoli W, Fabbri F, Ulivi P, Tesei A, Carloni S, Brigliadori G, Amadori D.

Anticancer Drugs. 2009 Nov;20(10):918-25. doi: 10.1097/CAD.0b013e32833179bf.

PMID:
19752719
8.

Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line.

Fabbri F, Brigliadori G, Carloni S, Ulivi P, Vannini I, Tesei A, Silvestrini R, Amadori D, Zoli W.

J Transl Med. 2008 Aug 8;6:43. doi: 10.1186/1479-5876-6-43.

9.

Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells.

Fabbri F, Amadori D, Carloni S, Brigliadori G, Tesei A, Ulivi P, Rosetti M, Vannini I, Arienti C, Zoli W, Silvestrini R.

J Cell Physiol. 2008 Nov;217(2):494-501. doi: 10.1002/jcp.21522.

PMID:
18615564
10.

Role of p53 codon 72 arginine allele in cell survival in vitro and in the clinical outcome of patients with advanced breast cancer.

Vannini I, Zoli W, Tesei A, Rosetti M, Sansone P, Storci G, Passardi A, Massa I, Ricci M, Gusolfino D, Fabbri F, Ulivi P, Brigliadori G, Amadori D, Bonafe M.

Tumour Biol. 2008;29(3):145-51. doi: 10.1159/000143400. Epub 2008 Jul 9.

PMID:
18612219
11.

Short interfering RNA directed against the SLUG gene increases cell death induction in human melanoma cell lines exposed to cisplatin and fotemustine.

Vannini I, Bonafe M, Tesei A, Rosetti M, Fabbri F, Storci G, Ulivi P, Brigliadori G, Amadori D, Zoli W.

Cell Oncol. 2007;29(4):279-87.

PMID:
17641412
12.

Iressa strengthens the cytotoxic effect of docetaxel in NSCLC models that harbor specific molecular characteristics.

Rosetti M, Zoli W, Tesei A, Ulivi P, Fabbri F, Vannini I, Brigliadori G, Granato AM, Amadori D, Silvestrini R.

J Cell Physiol. 2007 Sep;212(3):710-6.

PMID:
17458894
13.

Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines.

Rosetti M, Tesei A, Ulivi P, Fabbri F, Vannini I, Brigliadori G, Amadori D, Bolla M, Zoli W.

Apoptosis. 2006 Aug;11(8):1321-30.

PMID:
16699954
14.

Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: a cytometric study.

Fabbri F, Carloni S, Brigliadori G, Zoli W, Lapalombella R, Marini M.

BMC Cell Biol. 2006 Jan 26;7:6.

15.

Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.

Zoli W, Ulivi P, Tesei A, Fabbri F, Rosetti M, Maltoni R, Giunchi DC, Ricotti L, Brigliadori G, Vannini I, Amadori D.

Breast Cancer Res. 2005;7(5):R681-9. Epub 2005 Jun 22.

16.

Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells.

Fabbri F, Brigliadori G, Ulivi P, Tesei A, Vannini I, Rosetti M, Bravaccini S, Amadori D, Bolla M, Zoli W.

Apoptosis. 2005 Oct;10(5):1095-103.

PMID:
16151642
17.

Modulation of drug cytotoxicity by Iressa (ZD1839) in pancreatic cancer cell lines.

Rosetti M, Tesei A, Ulivi P, Fabbri F, Vannini I, Brigliadori G, Granato AM, Amadori D, Zoli W.

Cancer Biol Ther. 2005 Oct;4(10):1089-95. Epub 2005 Oct 7.

18.

Cellular basis of antiproliferative and antitumor activity of the novel camptothecin derivative, gimatecan, in bladder carcinoma models.

Ulivi P, Zoli W, Fabbri F, Brigliadori G, Ricotti L, Tesei A, Rosetti M, De Cesare M, Beretta GL, Corna E, Supino R, Zunino F.

Neoplasia. 2005 Feb;7(2):152-61.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk